LabCompass

Amanda Gusovsky

Medicine · The Ohio State University

Early career · publishing since 2021Rising activity

Publications

15

Citations

26

Est. group size

Recurring co-author estimate

Active years

6

Publishing since 2021

Research summary
AI-generated

Amanda Gusovsky's research focuses on real-world use of medications for chronic migraine, including comparisons between OnabotulinumtoxinA (a botulinum toxin treatment) and CGRP monoclonal antibodies (a newer class of migraine-prevention drugs). Work also spans broader topics in health data and treatment outcomes, such as antibiotic exposure after heart attacks, disease surveillance data policy, and diagnostic testing for respiratory infections. This suggests a research approach that draws on large healthcare claims and administrative datasets to study treatment patterns and patient adherence.

Chronic migraine treatment adherenceCGRP monoclonal antibody therapyBotulinum toxin (OnabotulinumtoxinA) useHealthcare claims and real-world data analysisInfectious disease surveillance and diagnostics

Publication output was minimal or absent for most of the past decade but has grown noticeably since 2021, with a marked increase from 2023 to 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.8/year recently
171819202021: 1 publication21222023: 3 publications232024: 5 publications5242025: 5 publications5252026: 1 publication26
Publishes in
  • Neurology×5
  • JU Open Plus×2
  • Journal of Pain and Symptom Management×2
  • Sexually Transmitted Diseases×1
  • JAMA Network Open×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile